What is the recommended age limit for Cologuard (multitarget stool DNA test) screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Age Limits for Cologuard (Multitarget Stool DNA Test) Screening

Cologuard screening should begin at age 45 and should be discontinued after age 75 for most patients, with consideration to stop earlier if life expectancy is less than 10 years.

Starting Age for Cologuard Screening

  • Age 45: Current guidelines recommend starting colorectal cancer screening at age 45 for average-risk individuals 1, 2

    • The American Cancer Society (ACS) lowered the recommended starting age from 50 to 45 years in 2018 1
    • The US Multi-Society Task Force now suggests offering CRC screening to all average-risk individuals ages 45-49 2, 3
  • Rationale for starting at age 45:

    • CRC incidence in adults aged 40-49 years has increased by almost 15% from 2000-2002 to 2014-2016 2
    • The rate of advanced colorectal neoplasia in average-risk individuals ages 45-49 is similar to rates observed in screening cohorts of those ages 50-59 2, 3
    • Modeling studies demonstrate that starting screening at age 45 provides additional life-years gained (LYG) compared to starting at age 50 1

Stopping Age for Cologuard Screening

  • Age 75: Most guidelines recommend stopping routine colorectal cancer screening at age 75 for those with adequate prior screening history 1, 2

    • The USPSTF concludes with moderate certainty that the net benefit of screening for colorectal cancer in adults aged 76 to 85 years who have been previously screened is small 1
    • The American College of Physicians (ACP) explicitly recommends stopping screening for colorectal cancer in adults over the age of 75 years 1
  • Considerations for ages 76-85:

    • Screening decisions should be individualized based on:
      1. Prior screening history (those never screened may benefit more)
      2. Overall health status and comorbidities
      3. Life expectancy (should be at least 10 years to realize mortality reduction benefits)
      4. Patient preferences 1, 2
  • Age 85+: Screening is not recommended after age 85 years 1, 2, 3

    • The ACS specifically discourages screening over age 85 1

Special Considerations for Cologuard (Multitarget Stool DNA Test)

  • Cologuard is recommended every 3 years as a screening option 1, 2
  • Limitations specific to Cologuard in older adults:
    • The specificity of Cologuard decreases with increasing age, with only 83% specificity in persons aged >65 years 2
    • Higher false positive rates in older adults lead to unnecessary follow-up colonoscopies, which carry increased risks in elderly patients 2
    • A positive Cologuard test requires follow-up colonoscopy, which has higher complication rates in elderly patients 2

Risk-Based Adjustments

  • Family history: Begin screening at age 40 or 10 years before the age of diagnosis of the youngest affected relative (whichever is earlier) 2
  • African American individuals: Some guidelines recommend starting screening at age 40 due to higher CRC incidence 1
  • Prior negative colonoscopy: Patients with a prior negative colonoscopy 10+ years before reaching age 76-85 have lower risk and may safely discontinue screening 4

Clinical Pitfalls to Avoid

  • Overscreening: Colonoscopy is frequently overused in elderly patients, including repeated screening at less than 10-year intervals and routine screening of patients older than 80 years 1
  • Underscreening: Failing to offer screening to patients aged 45-49, despite increasing CRC incidence in this age group 5
  • Ignoring prior screening history: Prior negative screening results significantly impact the benefit-to-harm ratio of continued screening in older adults 4
  • Overlooking life expectancy: Screening benefits require at least 10 years of life expectancy to realize mortality reduction 2

By following these evidence-based age guidelines for Cologuard screening, clinicians can maximize the benefits of colorectal cancer detection while minimizing unnecessary testing and potential harms in both younger and older populations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Colorectal Cancer Screening Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

At What Age Should We Stop Colorectal Cancer Screening? When Is Enough, Enough?

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2023

Research

Is it time to lower the recommended screening age for colorectal cancer?

Journal of the American College of Surgeons, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.